TT BioPharm Has Received A Decision To Grant European Patent Number EP3283620 Titled "Modified Gamma Delta Cells And Uses Thereof (For The Treatment Of Cancer Or Infectious Diseases In A Human)"
TT BioPharm Has Received A Decision To Grant European Patent Number EP3283620 Titled "Modified Gamma Delta Cells And Uses Thereof (For The Treatment Of Cancer Or Infectious Diseases In A Human)"
TT BioPharm 已收到一项授予欧洲专利号 EP3283620 的决定,该专利号为 “改性伽玛三角洲细胞及其用途(用于治疗人类癌症或传染病)”
EP About this file - European Patent Register (epo.org)
EP 关于此文件-欧洲专利注册局 (epo.org)
![Image](https://usnewsfile.moomoo.com/public/MM-PersistNewsContentImage/7781/20240322/0-c69b13861a89f199c276bba81a77efd4-0-a7fc5e6ed317063f460ca73f8d46f720.jpg/big)